Phase I Study of Aprotinin in Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Aprotinin
Sponsor: Dartmouth-Hitchcock Medical Center